Table 2.
Evaluation of efficacy after treatment
| Tumor response | Induction IC Group | CCRT group | ||
|---|---|---|---|---|
| After induction therapy, n (%) | After CCRT, n (%) | After all treatments, n (%) | After CCRT, n (%) | |
| CR | 2 (3.28) | 5 (8.20) | 9 (14.75) | 1 (1.41) |
| PR | 48 (78.69) | 17 (27.87) | 43 (70.49) | 18 (25.35) |
| SD | 9 (14.75) | 36 (59.01) | 6 (9.84) | 44 (61.97) |
| PD | 2 (3.28) | 1 (1.64) | 1 (1.64) | 5 (7.04) |
| NE | 0 (0.00) | 2 (3. 28) | 2 (3.28) | 3 (4.23) |
IC Induction immunotherapy plus chemotherapy; CCRT Concurrent chemoradiotherapy; CR Complete remission; PR Partial response; SD Stable disease; SD Progressive disease; NE Not evaluable